The role of law and governance reform in the global response to non-communicable diseases.

Publisher: BioMed Central Country of Publication: England NLM ID: 101245734 Publication Model: Electronic Cited Medium: Internet ISSN: 1744-8603 (Electronic) Linking ISSN: 17448603 NLM ISO Abbreviation: Global Health Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2005-

Health Policy*; Chronic Disease/*epidemiology ; Chronic Disease/*prevention & control ; Global Health/*legislation & jurisprudence ; Health Services Accessibility/*organization & administration; Developing Countries ; Financing, Organized/legislation & jurisprudence ; Global Health/economics ; Health Behavior ; Health Priorities ; Health Services Accessibility/economics ; Health Services Accessibility/legislation & jurisprudence ; Health Services Needs and Demand ; Humans ; Leadership ; Risk Factors

Addressing non-communicable diseases ("NCDs") and their risk-factors is one of the most powerful ways of improving longevity and healthy life expectancy for the foreseeable future - especially in low- and middle-income countries. This paper reviews the role of law and governance reform in that process. We highlight the need for a comprehensive approach that is grounded in the right to health and addresses three aspects: preventing NCDs and their risk factors, improving access to NCD treatments, and addressing the social impacts of illness. We highlight some of the major impediments to the passage and implementation of laws for the prevention and control of NCDs, and identify important practical steps that governments can take as they consider legal and governance reforms at country level.We review the emerging global architecture for NCDs, and emphasise the need for governance structures to harness the energy of civil society organisations and to create a global movement that influences the policy agenda at the country level. We also argue that the global monitoring framework would be more effective if it included key legal and policy indicators. The paper identifies priorities for technical legal assistance in implementing the WHO Global Action Plan for the Prevention and Control of NCDs 2013-2020. These include high-quality legal resources to assist countries to evaluate reform options, investment in legal capacity building, and global leadership to respond to the likely increase in requests by countries for technical legal assistance. We urge development agencies and other funders to recognise the need for development assistance in these areas. Throughout the paper, we point to global experience in dealing with HIV and draw out some relevant lessons for NCDs.

Lancet. 2012 Jan 21;379(9812):283-5. (PMID: 21982516)
Am J Law Med. 2013;39(2-3):218-36. (PMID: 23815029)
Am J Public Health. 2012 Nov;102(11):2010-2. (PMID: 22994178)
Lancet. 2011 Jul 30;378(9789):449-55. (PMID: 21665266)
Lancet. 2011 Sep 3;378(9794):859-60. (PMID: 21890035)
Lancet. 2010 Nov 20;376(9754):1785-97. (PMID: 21074253)
Tob Control. 2008 Dec;17(6):426-7. (PMID: 19029365)
Glob Heart. 2012 Mar;7(1):7-12. (PMID: 25691164)
Public Health. 2009 Mar;123(3):265-74. (PMID: 19278695)
Circulation. 2005 May 24;111(20):2684-98. (PMID: 15911719)
Lancet. 2012 Mar 31;379(9822):1269-71. (PMID: 21963004)
Kennedy Inst Ethics J. 2014 Sep;24(3):267-99. (PMID: 25423851)
Tob Control. 2013 Jan;22(1):46-51. (PMID: 22535364)
Bull World Health Organ. 2007 Apr;85(4):279-88. (PMID: 17546309)
Perspect Biol Med. 2003 Summer;46(3 Suppl):S199-209. (PMID: 14563083)
PLoS Med. 2012;9(6):e1001242. (PMID: 22723746)
Lancet. 2012 Oct 13;380(9850):1283-5. (PMID: 23063272)
Public Health. 2011 Dec;125(12):840-846. (PMID: 22054908)
PLoS Med. 2010 Aug 31;7(8):. (PMID: 20824175)
Lancet. 2012 Mar 3;379(9818):779-80. (PMID: 22386013)
BMJ. 2010 Jun 08;340:c2161. (PMID: 20530563)
Lancet. 2012 Dec 15;380(9859):2095-128. (PMID: 23245604)
Salud Publica Mex. 2010;52 Suppl 2:S288-97. (PMID: 21243201)
Am J Public Health. 2012 Jan;102(1):178-83. (PMID: 22095333)
Lancet. 2013 Feb 16;381(9866):575-84. (PMID: 23410607)
J Law Med Ethics. 2010 Fall;38(3):520-49. (PMID: 20880239)
BMJ. 2012 Mar 02;344:e586. (PMID: 22389336)
Lancet. 2011 Aug 27;378(9793):741. (PMID: 21872731)
Addiction. 2009 Oct;104(10):1623-9. (PMID: 21265905)
J Health Popul Nutr. 2000 Dec;18(3):123-30. (PMID: 11262764)
Health Aff (Millwood). 2010 Mar-Apr;29(3):379-87. (PMID: 20194976)
Hastings Cent Rep. 2013 Sep-Oct;43(5):19-25. (PMID: 24092587)
BMJ. 2013 Oct 31;347:f6189. (PMID: 24179043)
Lancet. 2007 Dec 15;370(9604):2044-53. (PMID: 18063027)
Global Health. 2011 Jul 04;7:21. (PMID: 21726434)
Tob Control. 2012 Jul;21(4):402-6. (PMID: 21602536)
Global Health. 2007 May 22;3:2. (PMID: 17519005)
Health Policy. 2014 Feb;114(2-3):163-73. (PMID: 24309298)
Lancet. 2009 Jan 17;373(9659):240-9. (PMID: 19042012)
Lancet. 2008 Dec 13;372(9655):2047-85. (PMID: 19097280)
Lancet. 2007 Dec 15;370(9604):2054-62. (PMID: 18063025)
Hastings Cent Rep. 2014 Jan-Feb;44(1):3-4. (PMID: 24408587)
Am J Public Health. 2010 Feb;100(2):240-6. (PMID: 20019306)
Bull World Health Organ. 2013 Oct 1;91(10):790-3. (PMID: 24115803)
Obesity (Silver Spring). 2009 May;17(5):941-64. (PMID: 19165161)
PLoS Med. 2013;10(7):e1001485. (PMID: 23935456)
Lancet. 2012 Dec 15;380(9859):2224-60. (PMID: 23245609)
Global Health. 2014 Jan 06;10:3. (PMID: 24393270)
Lancet. 2014 May 3;383(9928):1549-60. (PMID: 24680633)
Lancet. 2009 Feb 7;373(9662):433. (PMID: 19200899)
Bull World Health Organ. 2010 Jun;88(6):402. (PMID: 20539847)
Am J Law Med. 2013;39(2-3):199-217. (PMID: 23815028)
Bull World Health Organ. 2013 Aug 1;91(8):602-11. (PMID: 23940408)
Glob Public Health. 2011;6(3):247-56. (PMID: 21390970)
Health Policy. 2013 May;110(2-3):186-97. (PMID: 23506799)
N Engl J Med. 2013 Oct 3;369(14):1336-43. (PMID: 24088093)
Glob Heart. 2012 Mar;7(1):67-71. (PMID: 25691169)
BMC Public Health. 2012 Oct 16;12:877. (PMID: 23067232)
BMC Med. 2010 Jan 20;8:8. (PMID: 20089155)
Public Health. 2006 Dec;120(12):1149-55. (PMID: 17067645)
Public Health. 2009 Jan;123(1):e6-e10. (PMID: 19135693)
CA Cancer J Clin. 2011 Mar-Apr;61(2):67-8. (PMID: 21296854)
Obes Rev. 2013 Nov;14 Suppl 2:159-68. (PMID: 24103073)
Bull World Health Organ. 2014 Feb 1;92(2):139-45. (PMID: 24623907)
Lancet. 2013 Feb 23;381(9867):670-9. (PMID: 23410611)
N Engl J Med. 2008 Jul 31;359(5):482-91. (PMID: 18669427)
Lancet. 2013 Dec 7;382(9908):1898-955. (PMID: 24309475)
Ethics Int Aff. 2002;16(2):47-55. (PMID: 15709278)
Int J Pediatr Obes. 2006;1(3):133-8. (PMID: 17899630)
Global Health. 2013 Oct 16;9:46. (PMID: 24131595)
Public Health. 2014 Feb;128(2):151-60. (PMID: 24393497)
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. (PMID: 19896746)
N Engl J Med. 2009 Oct 15;361(16):1599-605. (PMID: 19759377)
Lancet. 2011 Aug 27;378(9793):752-3. (PMID: 21414659)
Lancet. 2011 Oct 1;378(9798):1231-43. (PMID: 21872920)
Bull World Health Organ. 2013 Jul 1;91(7):533-9. (PMID: 23825881)
Lancet. 2010 Nov 20;376(9754):1775-84. (PMID: 21074255)
BMJ. 2012 Aug 21;345:e5124. (PMID: 22915664)
Am J Clin Nutr. 2005 May;81(5):1198S-1205S. (PMID: 15883452)
Annu Rev Popul Law. 1989;16:1, 234-8. (PMID: 12344012)
Obes Rev. 2013 Oct;14 Suppl 1:1-12. (PMID: 24074206)
Public Health. 2011 Dec;125(12):832-839. (PMID: 22030320)
Lancet. 2011 Apr 23;377(9775):1438-47. (PMID: 21474174)
PLoS Med. 2012;9(6):e1001235. (PMID: 22745605)

Date Created: 20140607 Date Completed: 20141229 Latest Revision: 20231110

20240628

PMC4077679

10.1186/1744-8603-10-44

24903332